IUPAC nomenclature

(S)-2-[1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl] pyrrolidin-3-yl] -2,2-diphenyl-acetamide

Classification

Darifenacin is an acetylcholine antagonist. It is a muscarinic antagonist.

Physiochemical Properties

Mechanism of Action

Darifenacin acts as selective antagonist for the muscarinic receptors (M3). M3 receptors are involved in contraction of bladder, and hence, the drug helps in relaxing bladder. [1]

Structure Activity Relationship

• Either R₁ or R₂ must be heterocyclic or carbocyclic.
• The R₃ group can be hydrogen, hydroxyl, hydroxymethyl or amide.
• Most potent derivatives has X as an ester.
• X can also be either oxygen or absent completely.
• The N substituent can be quaternary ammonium salt or tertiary amine or both with different alkyl groups.
• Maximum potency obtained when the distance between the ring substituted carbons is 2 carbon units.

Method of synthesis

Reaction of 3-(S)-(-)-(1-carbamoyl-1,1-diphenylmethyl)- pyrrolidine with 5-(2-bromoethyl)benzo[2,3-b]furan in presence of anhydrous K2CO3 in acetonitrile to get darifenacin. [2]

Therapeutic Uses

Darifenacin is used for:

• Treatment of overactive bladder
• Reducing the frequent trips to bathroom
• Reducing the urge for frequent voids
• Reducing the leakage of urine

Side Effects

Side effects of Darifenacin are:

• Constipation
• Headache
• Dry mouth
• Blurred vision
• Dry eyes
• Tiredness
• Weakness
• Stomach upset
• Stomach pain

MCQ

Q.1 What can be the correct IUPAC nomenclature of Darifenacin?

a) (S)-2-[1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl] pyrrolidin-3-yl] -2,2-diphenyl-acetamide

b) (S)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol.

c) 7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid

d) N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide hemitartrate

Q.2 Which amongst the following statements is/are incorrect related to the SAR of Darifenacin?

I. Either R1 or R2 must be heterocyclic or carbocyclic.

II. The R3 group can be hydrogen, hydroxyl, hydroxymethyl or amide.

III. Poorest derivatives has X as an ester.

IV. ‘X’ can also be either oxygen or absent completely. 

a) I, II

b) III

c) III, IV

d) II

Q.3 Darifenacin can be obtained by reaction of 3-(S)-(-)-(1-carbamoyl-1,1-diphenylmethyl)- pyrrolidine with?

a) 5-(2-bromoethyl)benzo[2,3-b]furan

b) 1-phenylpropyl-4-methylphenol

c) 1,4-benzodiazepine-3-carboxylic acid

d) None of the above

Q.4 Side effects of drug darifenacin is/are?

a) Constipation

b) Headache

c) Dry mouth

d) All of the above

Q.5 Match the following drugs with their correct molecular weights-

a) i-C, ii-B, iii-A, iv-D

b) i-C, ii-B, iii-D, iv-A

c) i-A, ii-C, iii-D, iv-B

d) i-B, ii-A, iii-D, iv-C

Q.6 An example of drug from class Acetylcholine antagonist?

a) Zolpidem

b) Chlorazepate

c) Amphetamine

d) Darifenacin 

Q.7 The type of ring system found in the structure of darifenacin?

a) Dihydrobenzofurane

b) Pyrrolopyrimidine

c) Naphthalene

d) Pyrrolopyrrole ring 

For More Standard and Quality Question Bank you can Join Our Test Series Programme for GPAT, NIPER JEE, Pharmacist Recruitment Exam, Drug Inspector Recruitment Exams, PhD Entrance Exam for Pharmacy

Participate in  Free Online Test for GPAT, Pharmacist,Drug Inspector

ANSWERS

1-a

2-b

3-a

4-d

5-c

6-d

7-a

REFERENCES

The post DARIFENACIN Synthesis, SAR, MCQ,Structure,Chemical Properties and Therapeutic Uses appeared first on Gpatindia: Pharmacy Jobs, Admissions, Scholarships, Conference,Grants, Exam Alerts.